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Abstract 25 
 Cache Valley virus (CVV) induced malformations have been previously 26 
reproduced in ovine fetuses. To evaluate the development of the antiviral response by 27 
the early, infected fetus, before development of immunocompetency, ovine fetuses at 35 28 
days of gestation were inoculated in utero with CVV and euthanized at 7, 10, 14, 21 and 29 
28 days post infection. The antiviral immune response in immature fetuses infected with 30 
CVV was evaluated. Gene expression associated with an innate, immune response was 31 
quantified by real-time, quantitative PCR. Up-regulated genes in infected fetuses 32 
included ISG15, Mx1, Mx2, IL-1, IL-6, TNF-α, TLR-7 and TLR-8. The amount of Mx1 33 
protein, an interferon stimulated GTPase capable of restricting growth of bunyaviruses, 34 
was elevated in the allantoic and amniotic fluid in infected fetuses. ISG15 protein 35 
expression was significantly increased in target tissues of infected animals. B 36 
lymphocytes and immunoglobulin-positive cells were detected in lymphoid tissues and 37 
in the meninges of infected animals. These results demonstrated that the infected ovine 38 
fetus is able to initiate an innate and adaptive immune response much earlier than 39 
previously known. That presumably contributes to viral clearance in infected animals.   40 
 41 
Introduction 42 
Cache Valley virus (CVV) is a mosquito-borne bunyavirus of the family 43 
Bunyaviridae, genus Orthobunyavirus, Bunyamwera group (40), and endemic in North 44 
America (11). Serologic studies have shown that unlike most members of the family 45 
Bunyaviridae, the vectors of CVV also infect larger mammals with virus being isolated 46 
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from sheep, cattle and horses, and causing reproductive losses in small ruminants (7-9, 47 
11-14), similar to the disease caused by Akabane virus (5, 22, 32) and the newly 48 
identified Schmallenberg virus occurring in Europe (16). The virus has rarely been 49 
associated with meningoencephalitis in humans (4, 41). In utero ovine fetal infection 50 
causes abortion and fetal malformations, mainly affecting the musculoskeletal (MSS) 51 
and central nervous (CNS) systems (7-9, 11, 13, 37).  52 
Previous studies describing experimental CVV-induced malformations in ovine 53 
fetuses showed that the development of fetal lesions depends on the fetal age when 54 
infected. If the virus is inoculated between 28 and 48 days of gestation (dg), fetal death 55 
and abortion or MSS and CNS malformations occur. No apparent malformations are 56 
observed if the virus is inoculated after 48 dg (7, 11). Virus isolation can only be made 57 
from infected fetuses in early development, and viral recovery from tissues of term 58 
abortions and malformed lambs is uniformly unsuccessful. The virus is cleared from 59 
infected tissues within a few weeks after infection (11, 37) and before the presumed age 60 
of fetal immunocompetency, at approximately 70-75 dg (29, 33). 61 
The gestation period of the ewe is approximately 147 days. Ovine fetuses develop 62 
erythropoiesis, myelopoiesis and megakaryopoiesis in the yolk sac and liver at 63 
approximately 17 dg (30). At approximately 20 to 25 dg, lymphocyte production begins 64 
in the thymus, and lymphocytes are in the bloodstream at 48-50 dg (30). At 45-50 dg, T 65 
and B lymphocytes and cells with surface immunoglobulins are present in the spleen and 66 
lymph nodes (27, 28). The lymph nodes become integrated into a lymphatic system 67 
around 65 dg (30). Establishing the time when fetuses are able to respond to antigens is 68 
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difficult. Available data on adaptive immune response of ovine fetuses have been based 69 
on serum neutralization assays, which were established for use in mature animals. 70 
Additionally, gestation assay points used in experiments are somewhat arbitrary. Ovine 71 
fetal antibody response to viral infection at titers greater than 1:2 has been detected after 72 
76-78 dg (32).  Because the syndesmochorial placenta of ruminants prevents passage of 73 
immunoglobulins from the ewe to the fetus (45), antibodies in fetuses and precolostral 74 
newborns are those produced by the fetus. For this reason, in utero viral infections can 75 
be diagnosed in aborted fetuses and stillborn ruminants using serum neutralization tests.  76 
Such testing is necessary with CVV because the fetus clears the virus long before the 77 
end of gestation (9, 11). 78 
Previously, we have demonstrated that fetuses infected with CVV early in 79 
gestation (around 35 dg) have low viral antigen and RNA signal in tissues around 56 dg 80 
and are able to clear the infection before development of an adaptive immune system at 81 
75 dg (37). Similarly, age-based findings have been described in Akabane virus-infected 82 
fetuses (5, 29, 32). Because no effective serum neutralization antibody (an adaptive 83 
immune response) has been detected in ovine fetuses at the time when CVV is cleared 84 
from fetuses (30), it may be that the ovine fetus mounts an innate immune response for 85 
early viral clearance. To test this hypothesis, the expression of selected genes associated 86 
with the innate immune response was determined in tissues of CVV-infected and non-87 
infected ovine fetuses, and CVV mRNA was quantify  ed in selected tissues of these 88 
fetuses to correlate the measured innate response with viral clearance. In addition, fetal 89 
Mx protein, an interferon-stimulated GTPase previously associated with antiviral activity 90 
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against bunyaviruses (15, 23, 25, 38, 44), was quantified in the fetal allantoic and 91 
amniotic fluids. Expression of the interferon stimulated gene 15 (ISG15), that has been 92 
shown to be produced by fetuses in response to viral infection in utero (6, 42, 43), was 93 
evaluated in CVV-infected fetal tissues. Finally, distribution of B and T lymphocytes 94 
and immunoglobulin-positive cells was evaluated in infected and non-infected, ovine 95 
fetal tissues in early gestation.  96 
 97 
 Materials and methods 98 
Virus inoculation and sample harvesting  99 
A group of 15, seronegative, pregnant Rambouillet ewes was housed in BSL2 100 
confinement buildings according to protocols approved by The Institution Animal Care 101 
and Use and the Institutional Biosafety Committee. At 35 dg, ewes were inoculated in 102 
utero with a 1ml inoculum containing 105 50% tissue culture infectious doses (TCID50) 103 
of CVV (infected group) or 1 mL of minimum essential medium (MEM) (mock 104 
infected/control group), as previously described (37). The viral inoculum was derived 105 
from the second passage of an isolate from allantoic membrane from an experimentally 106 
infected fetus (7). At 7, 10, 14, 21 and 28 dpi, three ewes (one mock-infected and two 107 
virus-infected) were humanely euthanized.  Selected fetal tissues and their fluids were 108 
harvested and immediately frozen at -80ºC or placed in RNA later (Ambion, Life 109 
Technologies, Carlsbard, CA) and frozen at -80ºC. The remaining fetal tissues and 110 
placenta were fixed in 10% buffered formalin diluted in deionized water or in 111 
Davidson’s AFA (glacial acetic acid, 37% formaldehyde and 95% ethanol) fixative. 112 
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 113 
Real time quantitative polymerase chain reaction (qPCR) 114 
To quantify relative numbers of CVV RNA copies, and abundance of genes of 115 
interest, real time qPCR was performed on samples of brain and muscle harvested from 116 
CVV-infected or mock-infected ovine fetuses according to a previously published 117 
protocol with minor modifications (10). Briefly, RNA was isolated from harvested 118 
samples and homogenized in Trizol reagent (Gibco BRL, Bethesda, MD) according to 119 
the manufacturer’s recommendation. In order to eliminate contamination with genomic 120 
DNA, the extracted RNA was treated with the DNase1 amplification reagent (Invitrogen, 121 
Carlsbard, CA), and the RNA concentration was quantified by spectrophotometry. RNA 122 
quality was determined by denaturing samples in a 1.5% agarose gel electrophoresis 123 
stained with ethidium bromide and visualized on a UV transilluminator. The cDNA was 124 
synthesized from 500ng of total RNA combined with primer mix containing oligodT 125 
primer (0.2 µg/ml), random hexamer primer (300 µg/ml)(Invitrogen), dNTPmix (10mM 126 
each) and incubated at 65ºC for 5 min. After incubation, SuperScript II reverse 127 
transcriptase (Invitrogen) was added to the reaction according to manufacturer’s 128 
recommendations and reverse transcribed under the following conditions: 129 
25°C for 10 min; 42°C for 60 min and 70ºC for 5 min. To test for genomic DNA 130 
contamination, control reactions were prepared without reverse transcriptase.  131 
Specific oligonucleotide primers (Table 1) were generated in Oligo 5 program 132 
(Molecular Biology Insights, Inc) for the following genes: M segment of glycoprotein 1 133 
of CVV, interferon-α (IFN-α), IFN-β, TNF-α, IL-1, IL-6, Mx1, Mx2, ISG15, TLR7 and 134 
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TLR8. The real-time qPCR reaction was performed using the ABI prism 7900HT system 135 
(Applied Biosystems, Foster, CA) with power SYBR green PCR Master Mix (Applied 136 
Biosystems). Primer specificity and efficiency (-3.6>slope>-3.1) were confirmed using a 137 
test amplification run. The data were normalized using cycle threshold (Ct) values for 138 
the ovine glyceraldehyde 3-phosphate dehydrogenase (GADPH) gene in each sample. 139 
Semiquantitative analysis was calculated with the ΔΔCT method, and expressed as 140 
relative fold-changes compared with the lowest value for mock-infected samples. To 141 
calculate relative amounts of viral mRNA, relative fold-changes were compared with the 142 
infected sample with the lowest ΔΔCT. 143 
 144 
Protein slot blot  145 
The protein slot blot assay was used to determine and compare relative concentrations of 146 
the Mx1 protein in the fetal fluids of infected versus non infected fetuses. The starting 147 
concentration of protein in allantoic and amniotic fluids was determined using the 148 
Bradford Assay as recommended by the manufacturer (Bio-rad Laboratories). According 149 
to the protein concentration, samples were prepared and diluted to 12 µg of protein for 150 
the amniotic fluid and 50 µg of protein for the allantoic fluid in a final volume of 200 µl 151 
of Tris-Buffered saline (TBS). The volume was deposited onto a nitrocellulose 152 
membrane (Bio-Rad Laboratories, Richmond, CA) in a Bio-dot SF micro-filtration 153 
apparatus (Bio-Rad Laboratories) following a modified protocol as previously published 154 
(39). Briefly, nonspecific binding sites were blocked by immersing the membrane in 5% 155 
skim milk in TBS-Tween (TBST) for 1 h at room temperature on an orbital shaker. The 156 
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membranes were incubated overnight at 4°C in 2.5% milk-TBST containing a rabbit 157 
anti-ovine Mx1 polyclonal antibody (gift from Dr. Troy Ott, Penn State University) (24) 158 
at a concentration of 1:10000. The membrane was washed three times and then 159 
incubated for 1 h with goat anti-rabbit IgG (1:10000 dilution in 2.5% milk-TBST). 160 
Following incubation with the secondary antibody, the membrane was washed three 161 
times and further incubated for 1 min with Bio-Rad chemiluminescence reagent. The 162 
relative concentration of the Mx1 protein in triplicate samples was determined 163 
quantitatively in relative light units using the Bio-Rad chemidoc imager and assessed via 164 
use of Quantity One Image analysis software (39).  165 
 166 
Immunohistochemistry 167 
Immunohistochemistry was performed on 5 µm, deparaffinized sections of 168 
paraformaldehyde-fixed tissues mounted onto positively-charged, silanized slides using 169 
an automated system for immunohistochemistry (DakoCytomation Autostainer®, Dako, 170 
Carpinteria, CA) with minor modifications to the IHC protocol previously described 171 
(37). Antigen retrieval was performed in a decloaker chamber (Biocare Medical, 172 
Concord, CA) with slides soaked in citrate buffer pH 6.0.  Sections were incubated with 173 
anti-ISG15 polyclonal antibody (diluted 1:500) for 30 min (the antibody was a gift from 174 
Dr. Thomas Hansen, Colorado State University) (3), CD3 (diluted 1:400) polyclonal 175 
antibody for 35 min (Dako), anti-CD79a polyclonal antibody (diluted 1:200) for 30 min 176 
(Dako), anti-ovine IgG (diluted 1:500) for 35 min and anti-ovine IgM (diluted 1:2000) 177 
for 30 min (KPL, Inc, Gaithesburg, MA). The primary antibody was followed by 178 
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incubation with the secondary antibody (MACH 2 anti-rabbit Biocare Medical [CD3, 179 
IgG, IgM]; or ImmPress anti-Mouse Ig, Vector Labs [ISG15, CD79a]) for 20 min. A 180 
chromagen complex, 3,3-diaminobenzidine tetrachloride (DAB, Dako), was used to 181 
detect the targeted antigens, and sections were counterstained with hematoxylin. Slides 182 
were coverslipped with permount mounting solution. Tissues were evaluated to 183 
determine percentage of infected cells in each examined organ and graded as follows: 184 
less than 3% of cells positive (mild); between 3-15% of cells positive (moderate); more 185 
than 15% of cells positive (marked). 186 
 187 
Statistical analysis 188 
The quantitative data for mRNA expression and protein levels on fetal fluids were 189 
subjected to the Wilcoxon signed rank test to determine differences between infected 190 
and non-infected groups. Differences between groups at different dpi were subject to the 191 
one pair students t-test. In order to reduce heterogeneity among samples, the data were 192 
log-transformed if necessary, and p-values below 0.05% were considered statistically 193 
significant. The data are presented as means and overall standard errors. 194 
 195 
Results 196 
Real-time qPCR 197 
No significant difference in gene expression was observed either between infected 198 
animals at each different dpi or between control animals at different dg. Therefore, the 199 
data for each gene for each evaluated tissue were pooled into two groups: control and 200 
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infected animals (Fig. 1). qPCR analysis revealed, that IL-1, IL-6, Mx2, ISG15, TLR7 201 
and TLR8 were up-regulated (p-value <0.05) in the brain and skeletal muscle of CVV-202 
infected fetuses as compared to non-infected fetuses. Only in the brain was TNF-α 203 
significantly up-regulated. All examined genes but not ISG15 and Mx1, had higher up-204 
regulation in the brain as compared to the skeletal muscle (p-value <0.05). Similarly, the 205 
relative number of copies of CVV was significantly higher (p-value <0.05) in the brain 206 
when compared to the skeletal muscle (Fig. 2). Progressively lower means of relative 207 
number of copies of CVV were observed in both brain and skeletal muscle with the 208 
progression of the infection. A statistically significant difference (p-value <0.05) was 209 
observed in the brain of fetuses between 14-28 dpi (CVV in the brain of 10 dpi fetuses 210 
were excluded from analysis due to high variability among those samples), and in the 211 
SKM when comparing 10-14 dpi, 10-21 dpi, and 10-28 dpi. 212 
 213 
Protein slot blot 214 
A significant (p-value <0.01) increase in the amount of Mx1 protein in the 215 
allantoic and amniotic fluid occurred in infected fetuses versus non-infected fetuses at 216 
each time point examined (Fig. 3). Similar to the quantitative data collected with the real 217 
time qPCR, no effect of day or interaction of day versus infection was detected in 218 
evaluated samples.  219 
 220 
Immunohistochemistry for ISG15 221 
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 11
ISG15 was detected in several tissues of all infected fetuses, but no ISG15 222 
immunolabeling was observed in control fetuses (Fig. 4). In infected fetuses, a strong 223 
signal was observed in numerous cells of the cerebral parenchyma and meninges, and 224 
fewer cells were positive for ISG15 in the spinal cord.  Most fetuses at 7-21dpi had 225 
marked ISG15 antigen signal in the brain, with moderate signal observed at 28 dpi. The 226 
ISG15 antigen signal in the spinal cord of infected fetuses varied between mild to 227 
moderate at all test points. Multifocal clusters of cells with positive ISG15 228 
immunolabeling were observed in the SKM of infected fetuses through 21 dpi with only 229 
rare cells having a positive signal at 28 dpi. Other tissues with clusters of cells with 230 
positive signal included: heart, smooth muscle of intestine, tongue, fibroblasts in the 231 
subcutaneous tissue, wall of large arteries, cells around small blood vessels, spleen (one 232 
fetus at 21dpi), and rarely in the lungs, tonsils and thymus of earlier infected fetuses. 233 
 234 
Immunohistochemistry of B and T lymphocytes, IgG and IgM 235 
 At 7 dpi/42 dg, scattered CD79a positive cells were observed in the dorsal 236 
abdominal cellular lymphoid aggregates around the abdominal aorta, which correspond 237 
to sites of development of rudimentary renal or mesenteric lymph nodes, and rarely in 238 
the hepatic sinusoids in both control and infected animals. At 10 dpi/45 dg, slightly 239 
increased numbers of CD79a, IgG and IgM-positive cells were observed in the same 240 
locations in infected and control animals (Fig. 5, A-C). Rare IgM-positive cells were 241 
observed in the meninges of one infected animal. At 14 dpi/49 dg, slightly increased 242 
numbers of CD79a, IgG and IgM-positive cells were observed in the sites described 243 
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above, and at this timepoint, CD79a and IgM-positive cells were in the spleen of one of 244 
the infected animals (Fig. 5, D-F). Surprisingly, another infected animal also had a 245 
marked infiltration of CD79a, IgG and IgM-positive cells in the meninges of the brain 246 
and spinal cord and in rare cells within the parenchyma (Fig. 5, G-I). Increased numbers 247 
of CD79a, IgG and IgM-positive cells were arranged around splenic arterioles in both 248 
infected and control animals at 21 dpi/56 dg and 28 dpi/63 dg, besides also being in the 249 
previously described sites. Numerous IgG and IgM-positive cells were observed in the 250 
meninges of the spinal cord of two infected fetuses at 21 dpi, and rare immunoglobulin-251 
positive cells were observed in one fetus at 28 dpi. Moderate to marked numbers of CD3 252 
positive cells, evaluated only in sections of brain and transverse sections of the abdomen 253 
including the lumbar spinal cord of control and infected fetuses at 21 and 28 dpi, were 254 
detected in the spleen, renal and mesenteric lymph nodes in all fetuses. Scattered CD3 255 
positive cells were in the meninges of the BRA and SPC of one infected fetus at 14dpi 256 
and in the meninges of the SPC in one fetus at 21 dpi. 257 
 258 
Discussion 259 
Ovine fetuses are able to mount an immune response associated with CVV 260 
infection earlier in gestation than previously described (22, 29, 32, 33). Although the 261 
fetal immune response was not able to completely clear virus by the end of the study at 262 
63 dg (37), infected ovine fetuses were able to reduce the viral load within the CNS and 263 
MSS. Viral signal was also markedly reduced or absent in the ganglion, retina, kidney 264 
and heart. 265 
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CVV targets mainly cells within the CNS and MSS, and viral signal was markedly 266 
reduced in the brain and almost completely cleared in the skeletal muscle after 21-28 dpi 267 
in fetuses infected at 35 dg (37). Similarly, a progressive reduction in viral load, as 268 
shown by mean relative amounts of CVV RNA copies was observed in the brain and 269 
SKM in this study, with significant differences observed between most days of infection 270 
in the SKM, and in the brain between 14 and 28 dpi. In addition, in all groups, the 271 
relative number of CVV RNA copies in the brain was significantly higher than in the 272 
skeletal muscle.  273 
The Mx protein, an interferon stimulated GTPase involved in intracellular 274 
trafficking, membrane remodeling and fusion processes, is capable of restricting growth 275 
of viruses, including influenza virus, measles virus and bunyaviruses (including 276 
orthobunyavirus, phlebovirus and hantavirus genuses) (15, 17-20, 23, 25, 26, 44). In 277 
viral infections, the Mx protein acts by interfering with transport of viral components in 278 
infected cells. In a model proposed by Haller and Kochs (2002) (18), MxA forms large, 279 
membrane-associated self-assemblies that store monomers of this protein. With 280 
infection, monomers bind to viral target structures, forming new assemblies involving 281 
viral intermediates that lead to mislocalization of viral components and consequent 282 
inhibition of viral replication (18). Human MxA has been shown to inhibit replication of 283 
La Crosse virus by binding to the viral nucleocapsid protein, and forming large 284 
copolymers that accumulate in the perinuclear region (25). Previous studies have 285 
demonstrated antiviral activity of bovine Mx2 in cattle infected with BVDV (21, 42). 286 
Because Mx has a demonstrated antiviral effect against bunyaviruses, this study 287 
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quantified expression of the Mx molecule in infected tissues. A significant up-regulation 288 
of ovine Mx1 and Mx2 was observed in evaluated tissues from infected fetuses compared 289 
to controls. Increased secretion of Mx1 was identified in fetal fluids in infected ovine 290 
fetuses. Thus, this protein likely contributes to the clearance of CVV infection. 291 
ISG15 was markedly up-regulated in the brain and in the skeletal muscle and 292 
highly expressed in the tissues from infected animals. Similar to the Mx protein, ISG15 293 
is induced by type I interferon, and has been associated with antiviral activity (43). In 294 
recent studies, ISG15 has been shown to conjugate to proteins in a manner similar to 295 
ubiquitin (1, 46). Modifications and interference of antiviral signaling pathways 296 
involving ISG15 are mechanisms used by Crimean-Congo hemorrhagic fever virus, a 297 
bunyavirus, to evade the innate immune response (1). Up-regulation of numerous ISG, 298 
including ISG15, and continuous stimulation of the innate antiviral response have been 299 
demonstrated in blood and tissues of bovine fetuses and cattle infected with BVDV (21, 300 
42). 301 
Although ISG15, Mx1 and Mx2 were abundantly expressed in all infected fetuses, 302 
the expression of other selected IFN-stimulated genes was not altered. Previous studies 303 
have demonstrated that ovine fetuses within the second and third trimester of gestation 304 
are able to produce levels of interferon similar or greater to those produced by adult 305 
animals in response to a viral infection (36). Since type I interferon-induced genes were 306 
up-regulated, it is presumed that expression of type I interferon genes were also up-307 
regulated at the same or similar times, and that due to the short half-life of type I 308 
interferons the timing of up-regulation of the type I interferon(s) was not detected at the 309 
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time points evaluated. Even though less likely, one must consider the possibility of up-310 
regulation of both ISG15 and ovine Mx by an interferon-independent pathway.  311 
CD79a-positive cells (B lymphocytes and plasma cells) were observed in the 312 
spleen of CVV-infected fetuses at 49 dg, which is in agreement with previous studies, 313 
that identified B lymphocytes in ovine fetal lymph nodes and spleen as early as 47-48 dg 314 
(27, 28, 34). Both infected and non-infected fetuses had scattered CD79a-positive, IgM 315 
and IgG-positive cells in lymphoid aggregates in the dorsal aspect of the abdominal 316 
cavity, sites of development of rudimentary renal and/or mesenteric lymph nodes, as 317 
early as 42 and 45 dg, respectively. The identification of CD79a-positive cells in 318 
regional lymph nodes earlier than observed in the fetal spleen, supports the previously 319 
proposed idea that extrasplenic sites have the potential of producing B lymphocytes (2, 320 
34), and potentially explains the fact that splenectomized fetuses are also capable of 321 
colonizing Peyer’s patches with B lymphocytes (34, 35). 322 
A marked infiltration of CD79a, IgM and IgG-positive cells was observed within 323 
the meninges with fewer cells within the parenchyma of the brain and spinal cord of 324 
infected fetuses at 49 dg. It appears that the ovine fetus not only mounts an innate 325 
immune response to a viral infection, but is also able to stimulate an adaptive immune 326 
response. Unfortunately, blood samples were not available from the fetuses during these 327 
experiments; therefore, fetal neutralizing antibodies could not be assayed. In ovine 328 
fetuses infected with Akabane virus, the earliest day of gestation where IgM and IgG-329 
positive cells were observed in tissues was 59-60 days gestation. Titers >1:4 were 330 
detected only after 100 dg (22, 31). Two other studies detected Akabane virus 331 
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neutralizing antibodies after 76-78 dg, with titers ranging from 8-64 in one of these 332 
studies (29, 32).  333 
CVV is a viral pathogen with a tropism for the ovine fetal CNS, skeletal muscle 334 
and fetal membranes. The study of early infection demonstrated that a tropism correlated 335 
well with the CNS and musculoskeletal malformations observed in spontaneous CVV 336 
disease. With CVV, the development of arthrogryposis probably has a multifactorial 337 
pathogenesis involving effects on developing neurons, myocytes, and fetal membranes. 338 
CVV is the only viral infection shown to cause oligohydramnios. The virus is partially 339 
cleared from most fetal tissues by approximately 65 dg (28dpi), before the presently 340 
accepted onset of ovine immunocompetence. 341 
The ovine fetus is able to mount an immune response associated with CVV 342 
infection earlier in gestation by up-regulation of genes that participate in the innate 343 
immune response. The infected fetus up-regulates Mx genes, which have been shown to 344 
restrict growth of bunyaviruses. In addition, cells of the adaptive immune response, 345 
CD79a-positive, IgM and IgG-positive cells, are found in large numbers in infected 346 
tissues. Whether the immunoglobulin in these cells is actually CVV specific is still 347 
unclear. Further studies should be conducted for better understanding of the immune 348 
system development in the ovine fetuses exposed to CVV and other viral infections. 349 
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 Table 1. Primer sequences used for RT-qPCR. 496 
Gene Symbol Accession Primer Sequences Forward                                               Reverse 
CVV AF082576.1 CAC CAG CGA AAT CCC AAT CAC CA CTC CAG ACA TAG CAC CCA CCA 
TNF-α X55152.1 CGG CGT GGA GCT GAA AGA CAA CTG CGA GTA GAT GAG GTA AA 
IL-1 NM_001009465.2 AGT GAT GGC TTG CTA CAG T CCG AGG TCC AGG TGT T 
IL-6 X68723.1 GAG GGA AAT CAG GAA ACT GT CTC GTT TGA GGA CTG CAT CT 
TLR7 HQ529279.1 ACT CCT TGG GGC TAG ATG GT GCT GGA GAG ATG CCT GCT AT 
TLR8 FJ905847.1 TCC ACA TCC CAG ACT TTC TA GTT CTT GTC CTC ACT CTC TT 
Mx1 JN377734.1 GTA CGA GCC GAG TTC TCC AA ATG TCC ACA GCA GGC TCT TC 
Mx2 NM_001078652.1 CAT CCA TAA ATC GCT CCC CTT GT GCT CCT CTG TCG CCC TCT GGT 
ISG15 FJ844480.1 TGA CGG TGA AGA TGC TAG GG ACT GCT TCA GCT CGG ATA CC 
IFN-α X55152.1 ACC CAG CAC ACC TTC CAG CTC TT CCT CGC AGC CCC TCC TC 
IFN-β EU276065.1 TGG TTC TCC TGC TGT GTT TCT C CGT TGT TGG AAT CGA AGC AA 
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Figure legends: 498 
Figure. 1. Relative levels of genes expression in brain and skeletal muscle of control and Cache 499 
Valley virus infected animals. *p < 0.05, **p < 0.01, ***p < 0.005.  500 
 501 
Figure 2. Relative number of Cache Valley virus RNA copies in main target tissues, brain (BRA) 502 
and skeletal muscle (SKM) after 10, 14, 21 and 28 dpi. *p < 0.05, **p < 0.01.  503 
 504 
Figure 3. Relative amounts of ovine Mx1 protein in allantoic and amniotic fluid in control and 505 
infected animals. The presented values (y axis) are the relative light units using the Bio-Rad 506 
chemidoc imager and assessed via use of Quantity One Image analysis software. The starting 507 
protein concentration for the samples from the allantoic fluid was 50 μg and for the amniotic 508 
fluid was 12 μg. The data was log transformed for normalization. The infected fetuses had 509 
relatively higher amounts of Mx1 protein in the allantoic and amniotic fluid when compared to 510 
the control fetuses. p < 0.005 511 
 512 
Figure 4. Immunohistochemistry for ISG15 in brain and skeletal muscle. A rabbit polyclonal 513 
antibody against ovine ISG15 protein was stained with DAB chromagen (brown) on the brain 514 
(A,B,C) and skeletal muscle (D,E,F) from 45 dg control fetuses (A,D) and from infected fetuses 515 
at 14 dpi (45 dg) (B,E) and 28 dpi (63 dg) (C,F). Numerous cells in the brain and skeletal muscle 516 
of infected fetuses are positive for ISG15. No positive cells were observed in tissues of control 517 
fetuses. 518 
 519 
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Figure 5. Immunohistochemistry for B cells, plasma cells and ovine IgG and IgM in lymph node, 520 
spleen and brain. A polyclonal antibody against B cells and plasma cells (CD79a), ovine IgG and 521 
ovine IgM was stained with DAB chromagen (brown). CD79a (A), IgG (B) and IgM (C) positive 522 
cells were observed in rudimentary lymph nodes at 42-45dg in control fetuses. CD79a (D), IgG 523 
(E) and IgM (F) positive cells were observed in the spleen of infected fetuses. A remarkable 524 
number of CD79a (G), IgG (H) and IgM (I) positive cells were seen in the leptomeninges of an 525 
infected fetus at 14 dpi. 526 
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